Page last updated: 2024-08-23

fosinopril and Hyperlipemia

fosinopril has been researched along with Hyperlipemia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdel-Salam, OM; Arbid, MS; el-Batran, SA; el-Shenawy, SM; Nofal, SM	1
Aberg, G; Beyer, S; Kowala, MC; Recce, R	1
Aberg, G; Grove, RI; Kowala, MC	1
Batlle, DC; Keilani, T; Levin, ML; Schlueter, WA	1
Drozdov, VN; Ivleva, AIa; Kobalava, ZhD; Kotovskaia, IuV; Moiseev, VS; Moryleva, ON	1

Trials

2 trial(s) available for fosinopril and Hyperlipemia

Article	Year
Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Annals of internal medicine, 1993, Feb-15, Volume: 118, Issue:4 Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hyperlipidemias; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Proteinuria	1993
[Fosinorm in the treatment of essential hypertension with a metabolic syndrome]. Terapevticheskii arkhiv, 1997, Volume: 69, Issue:8 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Syndrome; Time Factors	1997

Article

Year

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.

Annals of internal medicine, 1993, Feb-15, Volume: 118, Issue:4

Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hyperlipidemias; Kidney Diseases; Lipoprotein(a); Male; Middle Aged; Proteinuria

1993

[Fosinorm in the treatment of essential hypertension with a metabolic syndrome].

Terapevticheskii arkhiv, 1997, Volume: 69, Issue:8

Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Syndrome; Time Factors

1997

Other Studies

3 other study(ies) available for fosinopril and Hyperlipemia

Article	Year
Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats. Pharmacological research, 2004, Volume: 50, Issue:2 Topics: Alloxan; Animals; Blood Glucose; Blood Proteins; Carbamates; Cholesterol, LDL; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Therapy, Combination; Egypt; Fosinopril; Gliclazide; Hyperlipidemias; Hypolipidemic Agents; Lipids; Losartan; Male; Piperidines; Rats; Rats, Sprague-Dawley; Triglycerides	2004
Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril. Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:2 Topics: Analysis of Variance; Animals; Aorta, Thoracic; Arteriosclerosis; Blood Pressure; Captopril; Cell Count; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cricetinae; Diet, Atherogenic; Disease Models, Animal; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Image Processing, Computer-Assisted; Macrophages; Male	1995
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis, 1994, Volume: 108, Issue:1 Topics: Animals; Aorta; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Cricetinae; Foam Cells; Fosinopril; Heart Rate; Hyperlipidemias; Lipids; Macrophages; Male	1994